04.01.2015 Views

Capital Opportunities for Small Businesses - sbtdc

Capital Opportunities for Small Businesses - sbtdc

Capital Opportunities for Small Businesses - sbtdc

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PROFILES: VENTURE CAPITAL FUNDS ACTIVE IN NORTH CAROLINA<br />

(as of August 2011)<br />

Venture Firm<br />

Year<br />

Founded<br />

<strong>Capital</strong> Under<br />

Management<br />

Preferred Stage of<br />

Financing<br />

Preferred Size of<br />

Investment<br />

Preferred Industries<br />

Website Comments<br />

Delphi Ventures 1988 $1.1 billion Early Stage N/A<br />

Dow Venture <strong>Capital</strong> N/A >$350 million Start-up & Early Stage<br />

Easton Hunt <strong>Capital</strong><br />

Partners, LP (EHCP)<br />

Emerging Technology<br />

Partners, LLC (ETP)<br />

Envest Holdings, LLC-<br />

Envest Ventures I<br />

EuclidSR Partners-<br />

EuclidSR Partners II, LP<br />

Minimum: $250,000; Preferred:<br />

$500,000 to $5 million<br />

1993 >$110 million All Stages $1 million to $8 million<br />

N/A<br />

2000<br />

N/A<br />

($30 million<br />

projected)<br />

Early Stage (but will<br />

do Seed & Late Stage)<br />

Early Stage (~50%),<br />

Mid-Stage (~25%), &<br />

Later Stage/Buy-out<br />

(~25%)<br />

$500,000 to $3 million<br />

N/A $250 million All Stages $3 million to $10 million<br />

N/A<br />

Medical Devices & Diagnostics,<br />

Biotechnology, Healthcare Services.<br />

Life Sciences & Biotechnology,<br />

Communications & In<strong>for</strong>mation<br />

Technology, Electronics, and Materials<br />

Science. For a detailed list, visit:<br />

www.dow.com/venture/invest.<br />

Life Sciences; Industrial Manufacturing &<br />

Distribution; Software; and Energy.<br />

Exclusively in Life Sciences (antibody<br />

technologies, cell based technologies,<br />

drug delivery and discovery technologies,<br />

drug target discovery & validation,<br />

genome-based diagnostics, genomics<br />

tools, immunotherapy, proteomics).<br />

Broad ("expect a minimum of 50% to be<br />

invested in technology-based<br />

businesses").<br />

Healthcare (biotechnology, drug<br />

discovery & development technologies,<br />

medical device technologies);<br />

In<strong>for</strong>mation Technology; eHealth (the<br />

convergence of healthcare & IT).<br />

Frontier <strong>Capital</strong> LP 1999 $46 billion Expansion/growth $5-15 million Technology-enabled service businesses<br />

Gabriel Venture<br />

Partners<br />

N/A<br />

N/A<br />

Prefers to invest<br />

early, in emerging<br />

markets<br />

$500,000 to $7 million<br />

Communications & Networking, Internet,<br />

IT.<br />

99

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!